Announcing 2024 IFPA Conference President and Theme
The 7th IFPA Conference will be held June 27-29, 2024 in Stockholm Sweden. Dermatologists, rheumatologists, and experts from around the world will gather to share breakthroughs in psoriatic disease research.
Professor April Armstrong will lead the scientific program as the 2024 Conference President and Chair of the Scientific Executive Committee. Professor Armstrong is Associate Dean of Clinical Research at Keck School of Medicine at the University of Southern California. She will be supported by Professor Ulrich Mrowietz, Co-Chair in Dermatology and 2021 Conference President, Professor Laura Coates, Co-Chair in Rheumatology, and Barbra Bohannan, Secretary. Together, the Scientific Executive Committee will incorporate urgent topics and emerging research under the theme “Uncovering the broad spectrum of psoriatic disease.”
The IFPA Conference calls for breakthroughs in research that will improve understanding of all aspects of psoriatic disease. Delegates will explore psoriasis, psoriatic arthritis, and multiple comorbidities from a holistic perspective. Presentations will respect the highest scientific standards. In addition to earning CME credits, attendees will have the opportunity to network with patients, industry representatives, and investigative giants.
Registration will open next year. Visit ifpaconference.com to sign up for news and updates.
Contact information
Scientific program
For questions about the IFPA Conference and Scientific program, contact Barbra Bohannan, Secretary of the Scientific Executive Committee: barbra.bohannan@pso
Become a sponsor
For practical questions about the congress venue, accommodation, booths, exhibition and satellite meetings, contact Project Manager Hediye Arslan from MCI: hediye.arslan@mci-group.com
Press contact
Camille Lancelot is appointed Press Officer: camille.lancelot@ifpa-pso.com
About the IFPA Conference
The World Psoriasis & Psoriatic Arthritis Conferences bring together the leading psoriatic disease experts to present frontline clinical research in dermatology, rheumatology and beyond. Established in 2006, the IFPA Conference (also known as the World Psoriasis & Psoriatic Arthritis Conference) increases global recognition of the seriousness of psoriatic disease, develops a broader international perspective on the illness, and encourages collaboration to develop research and advocacy.
About IFPA
IFPA is the global organization uniting all people living with psoriatic disease – regardless of where they live, what kind of psoriatic disease they have, or how it affects their lives. IFPA’s members represent over 60 million people living with psoriatic disease worldwide. Together, they fight for progress. More information about IFPA is available at ifpa-pso.com.
